[HTML][HTML] Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders
S Rana, SD Burke, SA Karumanchi - American journal of obstetrics and …, 2022 - Elsevier
Preeclampsia is a devastating medical complication of pregnancy that can lead to significant
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
maternal and fetal morbidity and mortality. It is currently believed that there is abnormal …
Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome
H Stepan, M Hund, T Andraczek - Hypertension, 2020 - Am Heart Assoc
Placental dysfunction underlies a spectrum of perinatal pathologies, including preeclampsia
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …
and fetal growth restriction. Angiogenesis-related factors, including sFlt-1 (soluble fms-like …
[PDF][PDF] ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction
CC Lees, T Stampalija, AA Baschat… - Ultrasound in Obstetrics …, 2020 - arts.units.it
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a scientific
organization that encourages sound clinical practice, and high-quality teaching and …
organization that encourages sound clinical practice, and high-quality teaching and …
The placental basis of fetal growth restriction
RL Zur, WT Parks, SR Hobson - Obstetrics and Gynecology …, 2020 - obgyn.theclinics.com
The past decade has seen a substantial advancement in our understanding of placental
diseases that are associated with fetal growth restriction (FGR). 1 This increased …
diseases that are associated with fetal growth restriction (FGR). 1 This increased …
A maternal serum metabolite ratio predicts fetal growth restriction at term
Fetal growth restriction (FGR) is the major single cause of stillbirth and is also associated
with neonatal morbidity and mortality,, impaired health and educational achievement in …
with neonatal morbidity and mortality,, impaired health and educational achievement in …
Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor) ratio in Asian women with suspected …
X Bian, A Biswas, X Huang, KJ Lee, TKT Li… - …, 2019 - Am Heart Assoc
Current diagnostic criteria have limited clinical value for prediction of preeclampsia and fetal
adverse outcomes. The prediction of short-term outcome in pregnant women with suspected …
adverse outcomes. The prediction of short-term outcome in pregnant women with suspected …
[HTML][HTML] Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia
S Verlohren, SP Brennecke, A Galindo… - Pregnancy …, 2022 - Elsevier
Preeclampsia is associated with significant morbidity and mortality for mother and baby.
Although around 30% of all pregnancies are evaluated for preeclampsia, diagnosis is …
Although around 30% of all pregnancies are evaluated for preeclampsia, diagnosis is …
The possible role of placental morphometry in the detection of fetal growth restriction
N Salavati, M Smies, W Ganzevoort, AK Charles… - Frontiers in …, 2019 - frontiersin.org
Fetal growth restriction (FGR) is often the result of placental insufficiency and is
characterized by insufficient transplacental transport of nutrients and oxygen. The main …
characterized by insufficient transplacental transport of nutrients and oxygen. The main …
PlGF (placental growth factor) testing in clinical practice: evidence from a Canadian tertiary maternity referral center
K McLaughlin, JW Snelgrove, MC Audette, A Syed… - …, 2021 - Am Heart Assoc
There is little evidence evaluating angiogenic growth factor testing in real-world obstetric
settings. This investigation evaluated maternal and perinatal pregnancy outcomes …
settings. This investigation evaluated maternal and perinatal pregnancy outcomes …
Effectiveness of routine third trimester ultrasonography to reduce adverse perinatal outcomes in low risk pregnancy (the IRIS study): nationwide, pragmatic, multicentre …
J Henrichs, V Verfaille, P Jellema, L Viester, E Pajkrt… - bmj, 2019 - bmj.com
Objectives To investigate the effectiveness of routine ultrasonography in the third trimester in
reducing adverse perinatal outcomes in low risk pregnancies compared with usual care and …
reducing adverse perinatal outcomes in low risk pregnancies compared with usual care and …